10q10k10q10k.net
Adaptive Biotechnologies Corp

Adaptive Biotechnologies CorpADPTEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

Top Holders

Holder% OwnedSharesChangeAs of
Viking Global Investors LP20.70%
30.0M
—2024-02-14
Rubric Capital Management LP9.76%
14.4M
—2024-11-13
ARK8.85%
12.8M
—2024-01-29
BlackRock, Inc.7.90%
11.4M
—2024-01-26
The Vanguard Group7.21%
10.6M
flat2024-11-12
Integrated Core Strategies6.30%
9.3M
▲ +1.10pp2024-10-11
Nikko Asset Management Americas, Inc.5.24%
7.7M
—2024-11-08
Sumitomo Mitsui Trust Group, Inc.5.24%
7.7M
—2024-11-05
Matrix Capital Management Company LP0.44%
650.0K
—2024-11-13

Insider Transactions

Net 90d: −$40.03M · buys $0 / sells $40.03M
Range:
Action:
Role:
InsiderRoleAction
2026-04-24RUBINSTEIN JULIEPresident and COOOption exercise
14.7K
$8.46$124.5K
2026-04-24RUBINSTEIN JULIEPresident and COOSell (open market)
19.1K
$14.02$267.2K
2026-04-23RUBINSTEIN JULIEPresident and COOOption exercise
14.7K
$8.46$124.5K
2026-04-23RUBINSTEIN JULIEPresident and COOSell (open market)
19.1K
$13.74$261.9K
2026-04-22RUBINSTEIN JULIEPresident and COOOption exercise
14.7K
$8.46$124.5K
2026-04-22RUBINSTEIN JULIEPresident and COOSell (open market)
19.1K
$14.13$269.3K
2026-04-21RUBINSTEIN JULIEPresident and COOOption exercise
14.7K
$8.46$124.5K
2026-04-21RUBINSTEIN JULIEPresident and COOOption exercise
11.9K
$12.14$144.2K
2026-04-21RUBINSTEIN JULIEPresident and COOSell (open market)
30.9K
$14.66$453.6K
2026-04-20RUBINSTEIN JULIEPresident and COOOption exercise
14.7K
$8.46$124.5K
1–10 of 131
Page 1 / 14